Cite
APA Citation
Vivar, O., Shen, C., Frakes, J., Niu, J., Rosenberg, A., Weiss, J., Caudell, J., Jameson, K., Said, P., & Seiwert, T. (n.d.). pH-0053 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial. Radiotherapy and oncology, 161, S28–. http://access.bl.uk/ark:/81055/vdc_100144486929.0x00001e